Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
29.63
+0.89 (3.10%)
Nov 6, 2026, 4:00 PM EST - Market closed
Zymeworks Market Cap
Zymeworks has a market cap or net worth of $2.1 billion as of November 6, 2026. It is the 6,320th most valuable company in the world and the 1,712th biggest in the United States. Its market cap has increased by 54.97% in one year.
Market Cap
2.10B
Enterprise Value
1.80B
1-Year Change
54.97%
Global Rank
Country Rank
#1,712 United States
Category
ChartMarket Cap Chart
Since April 28, 2017, Zymeworks's market cap has increased from $329.40M to $2.10B, an increase of 538.29%. That is a compound annual growth rate of 21.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 2.10B | 6.70% |
| Dec 31, 2025 | 1.97B | 95.40% |
| Dec 31, 2024 | 1.01B | 38.65% |
| Dec 29, 2023 | 727.30M | 46.87% |
| Dec 30, 2022 | 495.20M | -35.10% |
| Dec 31, 2021 | 763.00M | -64.77% |
| Dec 31, 2020 | 2.17B | 20.97% |
| Dec 31, 2019 | 1.79B | 281.53% |
| Dec 31, 2018 | 469.30M | 143.92% |
| Dec 29, 2017 | 192.40M | -41.59% |
| Apr 28, 2017 | 329.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immunome | 2.21B |
| Aurinia Pharmaceuticals | 2.21B |
| Recursion Pharmaceuticals | 2.19B |
| Biohaven | 2.19B |
| Vera Therapeutics | 2.15B |
| Fortrea Holdings | 2.12B |
| Lakefront Biotherapeutics NV | 2.11B |
| Vir Biotechnology | 2.09B |